BFC Planning’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.2K Sell
1,495
-7,766
-84% -$138K ﹤0.01% 1872
2026
Q2
$148K Buy
9,261
+8,274
+838% +$137K 0.01% 1057
2026
Q1
$18.3K Buy
987
+76
+8% +$1.33K ﹤0.01% 1757
2025
Q4
$14.2K Buy
911
+45
+5% +$643 ﹤0.01% 1906
2025
Q3
$12.7K Buy
866
+174
+25% +$2.58K ﹤0.01% 1790
2025
Q2
$10.7K Buy
692
+224
+48% +$3.31K ﹤0.01% 1767
2025
Q1
$6.96K Buy
468
+181
+63% +$2.54K ﹤0.01% 1906
2024
Q4
$3.8K Hold
287
– – ﹤0.01% 2093
2024
Q3
$4.08K Buy
+287
New +$4.07K ﹤0.01% 2076

Other funds holding TAK

BFC Planning's TAK Position: Q3 2026 in Review

BFC Planning reduced its Takeda Pharmaceutical (TAK) stake by 84% in Q3 2026, selling an estimated $138K and leaving 1,495 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1872.

BFC Planning first reported a position in TAK in Q3 2024 and has held it in 9 quarters since. The position peaked at $148K in Q2 2026. 343 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • BFC Planning held 1,495 shares of Takeda Pharmaceutical worth $27.2K as of Q3 2026.
  • BFC Planning sold 7,766 Takeda Pharmaceutical shares in Q3 2026, an estimated $138K.
  • Takeda Pharmaceutical made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1872 holding.
  • BFC Planning first reported a position in Takeda Pharmaceutical in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Takeda Pharmaceutical position peaked at $148K in Q2 2026.
  • 343 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.